(Press-News.org) The therapeutic potential of medical marijuana and pure cannabidiol (CBD), an active substance in the cannabis plant, for neurologic conditions is highly debated. A series of articles published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), examine the potential use of medical marijuana and CBD in treating severe forms of epilepsy such as Dravet syndrome.
In a case study, Dr. Edward Maa, Chief of the Comprehensive Epilepsy Program at Denver Health in Denver, Colo., details one mother's experience of providing medical marijuana to her child with Dravet syndrome. The adjunct therapy, a strain of cannabis high in CBD and tetrahydrocannabinol (THC) known as Charlotte's Web, was given in conjunction with the patient's antiepileptic drug regimen. The child's seizure frequency was reduced from 50 convulsions per day to 2 to 3 nighttime convulsions per month.
"Colorado is "ground zero" of the medical marijuana debate," says Dr. Maa. "As medical professionals it is important that we further the evidence of whether CBD in cannabis is an effective antiepileptic therapy." Currently, 21 states and the District of Columbia (DC) have legalized marijuana for medical purposes according to GOVERNING magazine.
A counter-point article summarizes current scientific evidence of CBD use in epilepsy and other neurological or psychiatric disorders including anxiety, schizophrenia and addiction. Previous studies found that THC, the primary psychoactive substance and CBD the main non-psychoactive ingredient in cannabis, display anticonvulsive properties in animals. However, this research was conducted in acute animal models and data is limited for chronic recurrent seizures. Recent studies claim medical marijuana with high ratios of CBD to THC are more effective in seizure control, but the data was anecdotal and not well controlled.
"While cannabis has been used to treat epilepsy for centuries, data from double-blind randomized, controlled trials of CBD or THC in epilepsy is lacking," explains Dr. Orrin Devinsky, Director of the Comprehensive Epilepsy Center at NYU Langone Medical Center in New York and Saint Barnabas Institute of Neurology and Neurosurgery in New Jersey. "Randomized controlled studies of CBD in targeted epilepsy groups, such as patients with Dravet or Lennox-Gastaut syndromes, are in the planning stages."
Dr. Maria Roberta Cilio, Director of Research in Pediatric Epilepsy of the Comprehensive Epilepsy Center at UCSF Benioff Children's Hospital in San Francisco, agrees, "There is a critical need for new therapies, especially for childhood-onset treatment-resistant epilepsies that impair quality of life and contribute to learning and behavioral disorders. Rigorous investigation of the safety and efficacy of medical marijuana or individual components such as CBD are necessary for patients with epilepsy before any conclusion is made. "
"There is much interest in the therapeutic potential of medical marijuana and CBD in treating epilepsy," say Drs. Gary Mathern and Astrid Nehlig, Editors-in-Chief of Epilepsia. "We would like your perspective on this important issue and ask that patients, clinicians, and medical professionals visit http://surveys.verticalresponse.com/a/show/1539433/ea840f4206/0 to provide feedback on the use of medical marijuana in epilepsy."
INFORMATION:
These studies are published in Epilepsia. Media wishing to receive a PDF of the articles may contact sciencenewsroom@wiley.com.
Full citations: "The Case for Medical Marijuana in Epilepsy." Edward Maa and Paige Figi. Epilepsia; Published Online: May 22, 2014 (DOI: 10.1111/epi.12610).
URL Upon Publication: http://doi.wiley.com/10.1111/epi.12610
"Cannabidiol: Pharmacology and Potential Therapeutic Role in Epilepsy and Other Neuropsychiatric Disorders." Orrin Devinsky, Maria Roberta Cilio, Helen Cross, Javier Fernandez-Ruiz, Jacqueline French, Charlotte Hill, Russell Katz, Vincenzo Di Marzo, Didier Jutras-Aswad, William George Notcutt, Jose Martinez-Orgado, Philip J. Robson, Brian G. Rohrback, Elizabeth Thiele, Benjamin Whalley and Daniel Friedman. Epilepsia; Published Online: May 22, 2014 (DOI: 10.1111/epi.12631).
URL Upon Publication: http://doi.wiley.com/10.1111/epi.12631
"The Case for Assessing Cannabidiol in Epilepsy." Maria Roberta Cilio, Elizabeth A. Thiele and Orrin Devinsky. Epilepsia; Published Online: May 22, 2014 (DOI: 10.1111/epi.12635).
URL Upon Publication: http://doi.wiley.com/10.1111/epi.12635
Editorial: "From the Editors: Cannabidiol and Medical Marijuana for the Treatment Of Epilepsy." Gary Mathern, Astrid Nehlig and Michael Sperling. Epilepsia; Published Online: May 22, 2014 (DOI: 10.1111/epi.12647).
URL Upon Publication: http://doi.wiley.com/10.1111/epi.12647
Author Contact: Media wishing to speak with Dr. Edward Maa may contact Julie Lonborg with Denver Health at julie.lonborg@dhha.org. For Dr. Orrin Devinsky please contact Ryan Jaslow with NYU Langone Medical Center at Ryan.Jaslow@nyumc.org. Those wishing to speak with Dr. Maria Roberta Cilio should contact Karin Rush-Monroe with UCSF at Karin.rush-monroe@ucsf.edu.
About the Journal
Epilepsia is the leading, most authoritative source for current clinical and research results on all aspects of epilepsy. As the journal of the International League Against Epilepsy, subscribers every month will review scientific evidence and clinical methodology in: clinical neurology, neurophysiology, molecular biology, neuroimaging, neurochemistry, neurosurgery, pharmacology, neuroepidemiology, and therapeutic trials. For more information, please visit http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1528-1167.
About the International League Against Epilepsy
The International League Against Epilepsy (ILAE) is the world's preeminent association of physicians and health professionals working toward a world where no person's life is limited by epilepsy. Since 1909 the ILAE has provided educational and research resources that are essential in understanding, diagnosing and treating persons with epilepsy. The ILAE supports health professionals, patients, and their care providers, governments, and the general public worldwide by advancing knowledge of epilepsy.
About Wiley
Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.
Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's website can be accessed at http://www.wiley.com.
Could cannabis curb seizures? Experts weed through the evidence
2014-05-22
ELSE PRESS RELEASES FROM THIS DATE:
Scientists announce top 10 new species for 2014
2014-05-22
SYRACUSE, N.Y. — An appealing carnivorous mammal, a 12-meter-tall tree that has been hiding in plain sight and a sea anemone that lives under an Antarctic glacier are among the species identified by the SUNY College of Environmental Science and Forestry's (ESF) International Institute for Species Exploration (IISE) as the top 10 species discovered last year.
An international committee of taxonomists and related experts selected the top 10 from among the approximately 18,000 new species named during the previous year and released the list May 22 to coincide with the birthday, ...
Temperature influences gender of offspring
2014-05-22
Whether an insect will have a male or female offspring depends on the weather, according to a study led by Joffrey Moiroux and Jacques Brodeur of the University of Montreal's Department of Biological Sciences. The research involved experimenting with a species of oophagous parasitoid (Trichogramma euproctidis), an insect that lays its eggs inside a host insect that will be consumed by the future larvae. "We know that climate affects the reproductive behaviour of insects. But we never clearly demonstrated the effects of climate change on sex allocation in parasitoids," Moiroux ...
Decision to jettison end of life Liverpool Care Pathway 'too extreme'
2014-05-22
The decision to jettison the approach to care of the dying, known as the Liverpool Care Pathway (LCP), was "too extreme," given that its principles are widely regarded as among the best examples of palliative care in the world, argues a senior ethicist in the Journal of Medical Ethics.
The LCP, which was intended to transfer the principles of hospice care to hospitals, fell foul of poor application by healthcare professionals and widespread misunderstanding of its scope and purpose among the general public, argues Dr Anthony Wrigley of the Centre for Professional Ethics ...
Improved GP access in standard hours may trump extended opening times
2014-05-22
Improving family doctor access during standard working hours might be better for reducing out of hours service use than extending the opening times of GP surgeries, suggests research published online in Emergency Medicine Journal.
If the link between access and out of hours service use is causal, this approach could cut demand for the latter by a maximum of 11%, the findings indicate.
Difficulties getting to see a GP when needed have been blamed for fuelling the rise in demand for out-of-hours primary care services, including emergency care. But there is not much evidence ...
Training brain patterns of empathy using functional brain imaging
2014-05-22
An unprecedented research conducted by a group of neuroscientists has demonstrated for the first time that it is possible to train brain patterns associated with empathic feelings – more specifically, tenderness. The research showed that volunteers who received neurofeedback about their own brain activity patterns whilst being scanned inside a functional magnetic resonance (fMRI) machine were able to change brain network function of areas related to tenderness and affection felt toward loved ones. These significant findings could open new possibilities for treatment of ...
Protective proteins reduce damage to blood vessels
2014-05-22
Researchers have uncovered how proteins found in our blood can reduce damage caused to blood vessels as we age, and in conditions such as atherosclerosis and arthritis.
Calcification is a major risk factor for heart attack and stroke. Blood vessels can harden as calcium phosphate (CaP) crystals, normally found in bones and teeth, build up in soft tissue as we age or as a result of illness. This can lead to complications in patients with atherosclerosis, a major cause of death in the UK whereby arteries thicken and are at risk of becoming blocked.
However a team of scientists ...
Disruption of circadian rhythms may contribute to inflammatory disease
2014-05-22
A disruption of circadian rhythms, when combined with a high-fat, high-sugar diet, may contribute to inflammatory bowel disease and other harmful conditions, according to a recent study conducted by researchers at Rush University Medical Center. The study is online at the peer-reviewed, open-access journal, PLOS ONE.
"Circadian rhythms, which impose a 24-hour cycle on our bodies, are different from sleep patterns," said Robin M. Voigt, PhD, assistant professor at Rush Medical College and first author of the study. "Sleep is a consequence of circadian rhythms," Voigt said.
While ...
Surgical site infections associated with excess costs at Veterans Affairs hospitals
2014-05-21
Surgical site infections (SSIs) acquired by patients in Veterans Affairs (VA) hospitals are associated with costs nearly twice as high compared to patients who do not have this complication. The greatest SSI-related costs are among patients undergoing neurosurgery.
SSIs are associated with increased complications and death. Treatment can include long courses of antibiotics, physical therapy, hospital readmissions and reoperations. Costs associated with SSIs after surgery have been under scrutiny since the Centers for Medicare and Medicaid stopped paying for increased ...
Study examines prophylactic double mastectomy following breast cancer diagnosis
2014-05-21
Many women diagnosed with cancer in one breast consider, and eventually undergo, a contralateral prophylactic mastectomy (CPM) to remove both breasts, although few of them have a clinically significant risk of developing cancer in both breasts.
Patients deciding to undergo CPM as part of initial treatment for breast cancer is a growing challenge in management of the disease. Removing the unaffected breast has not been shown to increase survival. The Society of Surgical Oncology suggests CPM be considered for a minority of patients at higher than average risk of developing ...
Imaging examines risky decision making on brains of methamphetamine users
2014-05-21
Methamphetamine users showed less sensitivity to risk and reward in one region of the brain and greater sensitivity in other brain regions compared with non-users when performing an exercise involving risky decision making.
Deficiencies in decision making are linked to addiction. Chronic methamphetamine use is associated with abnormalities in the neural circuits of the brain involved in risky decision making. Faulty decision making is targeted in addiction therapy so understanding its causes could help in the development of more effective treatments.
The authors ...